Severely Thrombosed Transcatheter Aortic Valve 9 Months After Implantation

Thomas T Poels1, Leo Veenstra2, Vincent van Ommen2

  • 1Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Insights

Bioprosthetic aortic valve thrombosis is a rare but deadly complication following transcatheter aortic valve implantation. This case highlights a patient with a fully thrombosed valve 9 months post-procedure, emphasizing diagnosis and management strategies.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Devices

Background:

  • Transcatheter aortic valve implantation (TAVI) is a common procedure for aortic stenosis.
  • Bioprosthetic valve thrombosis (BVT) is a recognized, albeit infrequent, complication.
  • High mortality associated with untreated BVT necessitates prompt diagnosis and intervention.

Observation:

  • A case of complete thrombosis of a bioprosthetic aortic valve is presented.
  • The thrombosis occurred 9 months after the transcatheter aortic valve implantation procedure.
  • The patient presented with symptoms indicative of severe prosthetic valve dysfunction.

Findings:

  • Complete thrombosis of the transcatheter aortic valve prosthesis was confirmed.
  • Review of existing literature on diagnosis and management of BVT was conducted.
  • The case underscores the potential for late-onset and complete valve obstruction.

Implications:

  • Early recognition and appropriate management of BVT are crucial for patient survival.
  • Further research into risk factors and preventative strategies for BVT is warranted.
  • This case contributes to the understanding of the clinical presentation and therapeutic options for BVT.